Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 21Terminated 10Active not recruiting 6Unknown 3Withdrawn 2Recruiting 2

Sponsor Class

OTHER 72NIH 30NETWORK 12INDUSTRY 6OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 3Genitourinary 2Gastrointestinal 2Dermatologic 2CNS 2Sarcoma 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Melanoma 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Liposarcoma, Myxoid 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 185Carboplatin 129Cisplatin 100Paclitaxel 99Gemcitabine 84Pemetrexed 76durvalumab 75Nivolumab 67Docetaxel 55atezolizumab 52Cyclophosphamide 50Bevacizumab 48Dexamethasone 46Capecitabine 45Oxaliplatin 43Rituximab 40Lenalidomide 40130-nm albumin-bound paclitaxel 39Fluorouracil 38Fulvestrant 37Prednisone 32osimertinib 31olaparib 29Leucovorin 29fludarabine 28venetoclax 27Trastuzumab 27Doxorubicin 27Etoposide 25Cetuximab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × Radiation × Clear all
NCT04550260 2026-05-13

KUNLUN

AstraZeneca

Phase 3 Active not recruiting
640 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03132922 2026-05-07

MAGE-A4ᶜ¹º³²T for Multi-Tumor

USWM, LLC (dba US WorldMeds)

Phase 1 Active not recruiting
71 enrolled 20 charts
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT06194448 2026-03-06

NEOLA

AstraZeneca

Phase 2 Active not recruiting
76 enrolled
Thoracic

Lung Neoplasms

NCT04478279 2026-02-09

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Sapience Therapeutics

Phase 1/2 Active not recruiting
125 enrolled
BreastCNSDermatologicGenitourinary

Brain Neoplasms, Breast Neoplasms, Glioblastoma, Melanoma, Prostatic Neoplasms

NCT04752813 2026-01-26

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

BPGbio

Phase 2 Active not recruiting
50 enrolled
CNS

Glioblastoma

NCT03519971 2025-10-28

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

AstraZeneca

Phase 3 Active not recruiting
328 enrolled 23 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡